Section 245.710  Chemical Disclosure by Contractor

a)         A permittee shall be responsible to ensure that any contractor performing high volume horizontal hydraulic fracturing operations within this State on behalf of the permittee shall (Section 1-77(c) of the Act):

1)         be authorized to do business in this State  (Section 1-77(c)(1) of the Act);

2)         provide the Department with the following information:

A)        the contractor's business name, address, email address and telephone number;

B)        the well name, permit number and permittee name for the well on which HVHHF operations will be conducted; and

C)        the name, email address and telephone number of the person at the well site responsible for the HVHHF operations.

b)         No less than 21 calendar days before performing the first stimulation treatment of HVHHF operations, the contractor performing HVHHF operations on behalf of the permittee shall maintain and disclose to the Department separate and up-to-date master lists of (Section 1-77(c)(2) of the Act):

1)         the base fluid to be used during any high volume horizontal hydraulic fracturing operations within this State (Section 1-77(c)(2)(A) of the Act);

2)         all hydraulic fracturing additives to be used during any high volume horizontal hydraulic fracturing operations within this State (Section 1-77(c)(2)(B) of the Act); and

3)         all chemicals and associated Chemical Abstract Service numbers to be used in any high volume horizontal hydraulic fracturing operations within this State (Section 1-77(c)(2)(C) of the Act).

c)         Nothing in this Section shall prohibit the contractor performing high volume horizontal hydraulic fracturing operations on behalf of the permittee from adjusting or altering the contents of the fluid during the treatment process to respond to unexpected conditions, as long as all other requirements of the Act and this Part are met and the contractor notifies the Department by electronic mail within 24 hours of the specific details of departure from the initial treatment design and includes a brief explanation detailing the reason for the departure (Section 1-77(a) of the Act).